How do we perform intrauterine transfusions?
Transfusion · 2023
DOI: 10.1111/trf.17570 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transfusion, 2023. Verfasst von Elizabeth P Crowe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Erythroblastosis, Fetal, Fetal Diseases, Anemia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
Background
Intrauterine transfusion (IUT) is an invasive but critical and potentially life‐saving intervention for severe fetal anemia with demonstrated improvement in outcomes. The fetus is vulnerable to hemodynamic alterations and transfusion‐related adverse events; therefore, special consideration must be given to blood component selection and modification. There is widespread IUT practice variability, and existing guidance primarily relies on expert opinion and single center experiences. Study Design and Methods Experts in Maternal Fetal Medicine, Pediatric Hematology, and Transfusion Medicine from centers across the United States, collectively performing about 120 IUT annually, offer a multidisciplinary perspective on the performance of IUT and preparation of blood components. This perspective includes strategies for identifying an at‐risk fetus, communicating between disciplines, determining the necessary blood volume, selecting and processing blood components, documenting the procedure in medical record, and managing the neonate.
Results
Identifying an at‐risk fetus relies on review of the clinical history, non‐invasive monitoring, and laboratory evaluation. We recommend the use of relatively fresh, group O, cytomegalovirus‐safe, freshly irradiated, red blood cells (RBC) that are Hemoglobin S negative and antigen‐negative for any maternal antibody, if indicated. These RBC units should be concentrated to remove additives and increase the hematocrit thus minimizing fluctuations in fetal volume status. The units intended for IUT should be labeled clearly and the documentation of transfusion differentiated in the maternal medical record.
Discussion
An awareness of the technical, logistical, and regulatory considerations for IUT performance will facilitate improved communication and patient care, especially when rare units of RBC are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
- Department of Laboratory Medicine, Seattle Children's Hospital, Seattle, Washington, USA.
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
- The Johns Hopkins Center for Fetal Therapy, Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Elizabeth P Crowe, Rida Hasan, Nabiha H Saifee, Sara Bakhtary, Ruchika Goel
Zitieren
APA
Crowe, E. P., Hasan, R., Saifee, N. H., Bakhtary, S., Miller, J. L., Gonzalez-Velez, J. M., & Goel, R. (2023). How do we perform intrauterine transfusions?. Transfusion. https://doi.org/10.1111/trf.17570
Vancouver
Crowe EP, Hasan R, Saifee NH, Bakhtary S, Miller JL, Gonzalez-Velez JM, et al. How do we perform intrauterine transfusions?. Transfusion. 2023. doi:10.1111/trf.17570
BibTeX
@article{Crowe2023,
author = {Crowe, Elizabeth P and Hasan, Rida and Saifee, Nabiha H and Bakhtary, Sara and Miller, Jena L and Gonzalez-Velez, Juan M and Goel, Ruchika},
title = {How do we perform intrauterine transfusions?},
journal = {Transfusion},
year = {2023},
doi = {10.1111/trf.17570}
}
EUVIMED